---
title: "Medroxyprogesterone - Postmenopausal Osteoporosis"
sidebar: mydoc_sidebar
permalink: db00603-mesh-d015663-1.html
toc: false 
---


Path ID: `DB00603_MESH_D015663_1`
{% include image.html url="images/db00603-mesh-d015663-1.png" file="db00603-mesh-d015663-1.png" alt="db00603-mesh-d015663-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D008525 | Medroxyprogesterone | Drug |
| UniProt:P06401 | Progesterone receptor | Protein |
| GO:0050847 | Progesterone receptor signaling pathway | BiologicalProcess |
| UniProt:P03372 | Estrogen receptor | Protein |
| GO:0030520 | Intracellular estrogen receptor signaling pathway | BiologicalProcess |
| MESH:D015663 | Postmenopausal osteoporosis | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Medroxyprogesterone | INCREASES ACTIVITY OF | Progesterone Receptor |
| Progesterone Receptor | POSITIVELY REGULATES | Progesterone Receptor Signaling Pathway |
| Progesterone Receptor Signaling Pathway | TREATS | Postmenopausal Osteoporosis |
| Medroxyprogesterone | INCREASES ACTIVITY OF | Estrogen Receptor |
| Estrogen Receptor | POSITIVELY REGULATES | Intracellular Estrogen Receptor Signaling Pathway |
| Intracellular Estrogen Receptor Signaling Pathway | TREATS | Postmenopausal Osteoporosis |
|---------|-----------|---------|

Comment: Oral tablets containing medroxyprogesterone acetate are conjugated with estrogens and indicated to prevent postmenopausal osteoporosis. This gaph is for the combination drug.

Reference: 
  - [https://go.drugbank.com/drugs/DB00603](https://go.drugbank.com/drugs/DB00603)
